US · 1 sources covering this

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

Share:WhatsApp X Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

The HinduLean L·1h ago
Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
Read at The Hindu →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/b6d94b969783e87940df661b99a5b3a1ff194003"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy"></iframe>

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

How 1 sources are covering this

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

More from US

Microsoft to launch its next big Xbox console in 2028, handheld coming soon

Tamil Nadu government sanctions ₹71 crore to enhance contingency funds for police stations

iPhone 16 price drops by Rs 12,901 without conditions

Google Pixel 10 is available at a lower price on Amazon: Details here

Reader

Trust & legal

Across the network